He, X., Yu, J., & Shi, H. (2021). Pan-Cancer Analysis Reveals Alternative Splicing Characteristics Associated With Immune-Related Adverse Events Elicited by Checkpoint Immunotherapy. Frontiers Media S.A.
Style de citation Chicago (17e éd.)He, Xiujing, Jing Yu, et Hubing Shi. Pan-Cancer Analysis Reveals Alternative Splicing Characteristics Associated With Immune-Related Adverse Events Elicited by Checkpoint Immunotherapy. Frontiers Media S.A, 2021.
Style de citation MLA (8e éd.)He, Xiujing, et al. Pan-Cancer Analysis Reveals Alternative Splicing Characteristics Associated With Immune-Related Adverse Events Elicited by Checkpoint Immunotherapy. Frontiers Media S.A, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.